Induction of Chronic Subclinical Systemic Inflammation in Sprague–Dawley Rats Stimulated by Intermittent Bolus Injection of Lipopolysaccharide

[1]  A. Akim,et al.  Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review , 2017, Applied Biological Chemistry.

[2]  M. Haluzík,et al.  Lymphocytes and macrophages in adipose tissue in obesity: markers or makers of subclinical inflammation? , 2017, Protoplasma.

[3]  A. Hidalgo,et al.  Neutrophils in Homeostasis, Immunity, and Cancer. , 2017, Immunity.

[4]  Dominique Latinne,et al.  What is the normal value of the neutrophil-to-lymphocyte ratio? , 2017, BMC Research Notes.

[5]  J. Tenhunen,et al.  Abdominal Septic Shock – Endotoxin Adsorption Treatment (ASSET) – endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial , 2016, Trials.

[6]  Chen-feng Qi,et al.  The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis , 2016, Nature Communications.

[7]  S. B. Anderberg,et al.  Physiological aspects of Toll‐like receptor 4 activation in sepsis‐induced acute kidney injury , 2016, Acta physiologica.

[8]  Qian Wang,et al.  Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis , 2016, Nature Reviews Rheumatology.

[9]  A. Ismail,et al.  Alpha-amylase, antioxidant, and anti-inflammatory activities of Eucheuma denticulatum (N.L. Burman) F.S. Collins and Hervey , 2016, Journal of Applied Phycology.

[10]  B. Sokołowska,et al.  Inflammation increases oxidative DNA damage repair and stimulates preneoplastic changes in colons of newborn rats. , 2016, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[11]  Xue-qun Chen,et al.  Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia , 2016, Journal of Neuroinflammation.

[12]  Keqiang Chen,et al.  Subclinical-Dose Endotoxin Sustains Low-Grade Inflammation and Exacerbates Steatohepatitis in High-Fat Diet–Fed Mice , 2016, The Journal of Immunology.

[13]  G. Wegener,et al.  Chronic exposure to low doses of lipopolysaccharide and high-fat feeding increases body mass without affecting glucose tolerance in female rats , 2015, Physiological reports.

[14]  Z. Dong,et al.  Lipopolysaccharide Induces Chronic Kidney Injury and Fibrosis through Activation of mTOR Signaling in Macrophages , 2015, American Journal of Nephrology.

[15]  J. Pérez‐Ramos,et al.  Effects of Kramecyne on LPS Induced Chronic Inflammation and Gastric Ulcers , 2015, Drug development research.

[16]  R. Weiskirchen,et al.  Lipopolysaccharide-induced inflammatory liver injury in mice , 2015, Laboratory animals.

[17]  G. Wegener,et al.  Chronic lipopolysaccharide infusion fails to induce depressive-like behaviour in adult male rats , 2015, Acta Neuropsychiatrica.

[18]  N. Terrando,et al.  Prolonged Neuroinflammation after Lipopolysaccharide Exposure in Aged Rats , 2014, PloS one.

[19]  D. Hickman,et al.  Evaluation of the neutrophil-lymphocyte ratio as a measure of distress in rats , 2014, Lab Animal.

[20]  M. Scobey,et al.  The Risk of Colon Cancer in Inflammatory Bowel Disease , 2014 .

[21]  N. Dalton,et al.  Recurrent Exposure to Subclinical Lipopolysaccharide Increases Mortality and Induces Cardiac Fibrosis in Mice , 2013, PloS one.

[22]  Marie E. Latulippe,et al.  A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies , 2013, British Journal of Nutrition.

[23]  Hee Kang,et al.  Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models , 2012, BMC Complementary and Alternative Medicine.

[24]  J. Tamaoki,et al.  Chronic Low-Grade Systemic Inflammation Causes DNA Damage in the Lungs of Mice , 2012, Lung.

[25]  H. Noguchi,et al.  Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease , 2011, Experimental diabetes research.

[26]  I. Autenrieth,et al.  Gene-environment interactions in chronic inflammatory disease , 2011, Nature Immunology.

[27]  A. Leite-Moreira,et al.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases , 2010, Hepatology international.

[28]  J. S. Janicki,et al.  Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats , 2010, Hypertension.

[29]  S. Amini,et al.  Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[30]  S. Du,et al.  Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen , 2009, Innate immunity.

[31]  H. Spapen.  Liver Perfusion in Sepsis, Septic Shock, and Multiorgan Failure , 2008, Anatomical record.

[32]  L. Marnell,et al.  C-reactive protein at the interface between innate immunity and inflammation , 2008, Expert review of clinical immunology.

[33]  Yosuke Osawa,et al.  TLR4 enhances TGF-β signaling and hepatic fibrosis , 2007, Nature Medicine.

[34]  T. Takata,et al.  Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. , 2007, Journal of periodontology.

[35]  P. Stenvinkel,et al.  Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences. , 2007, Clinical nephrology.

[36]  F. Verrecchia,et al.  Transforming growth factor-β and fibrosis , 2007 .

[37]  B. Pedersen,et al.  Human Models of Low-Grade Inflammation: Bolus versus Continuous Infusion of Endotoxin , 2007, Clinical and Vaccine Immunology.

[38]  B. Aggarwal,et al.  Inflammation and cancer: how hot is the link? , 2006, Biochemical pharmacology.

[39]  K. Janardhan,et al.  Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. , 2006, Histology and histopathology.

[40]  M. Lerner,et al.  Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. , 2006, Bone.

[41]  Kun‐Lun Huang,et al.  Effects of various body temperatures after lipopolysaccharide-induced lung injury in rats. , 2005, Chest.

[42]  Gerene M Denning,et al.  Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[44]  H. Katus,et al.  TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. , 2002, Cardiovascular research.

[45]  M. West,et al.  Endotoxin tolerance: A review , 2002, Critical care medicine.

[46]  P. Bongrand,et al.  The IL-6-Soluble IL-6Rα Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin , 2001, The Journal of Immunology.

[47]  A. Armario,et al.  Single exposure to stressors causes long-lasting, stress-dependent reduction of food intake in rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[48]  V. Fraifeld,et al.  Effects of lipopolysaccharide on body temperature and plasma zinc and iron concentrations in rats exposed to different ambient temperatures , 2000 .

[49]  G. Reaven,et al.  Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women , 1992, Journal of internal medicine.

[50]  D. Overstreet,et al.  Measurement of temperature in the rat by rectal probe and telemetry yields compatible results , 1992, Pharmacology Biochemistry and Behavior.

[51]  A. Vander,et al.  Effects of chronic infusion of lipopolysaccharide on food intake and body temperature of the rat , 1988, Physiology & Behavior.

[52]  U. Apte,et al.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer. , 2015, Advances in pharmacology.

[53]  D. Webb.  Animal models of human disease: inflammation. , 2014, Biochemical pharmacology.

[54]  D. Popov,et al.  SEPSIS MODELS IN EXPERIMENTAL ANIMALS , 2013 .

[55]  M. Lerner,et al.  Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. , 2009, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[56]  F. Verrecchia,et al.  Transforming growth factor-beta and fibrosis. , 2007, World journal of gastroenterology.

[57]  W. Langhans.  Cytokines in Chronic Inflammation , 2006 .

[58]  R. Mowry,et al.  Staining methods, histologic and histochemical , 1964 .